Lamoon, Inc. v. Lamour Nail Products, Inc.
This text of 373 F. App'x 795 (Lamoon, Inc. v. Lamour Nail Products, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
MEMORANDUM **
In March 2007, Lamoon, Inc. (“La-moon”) and Lamour Nail Products, Inc. (“Lamour”) entered into a settlement agreement terminating a trademark infringement lawsuit by Lamoon against Lamour. In 2008, Lamoon brought suit against Alfalfa Nail Supply, Inc., Regal Nails Salon & Spa LLC, and a Regal Nails franchise (collectively “Alfalfa Defendants”), distributors of Lamour’s products. The Alfalfa Defendants filed a third-party complaint against Lamour for indemnity and contribution. Along with its answer to the third-party complaint, third-party defendant Lamour asserted claims against plaintiff Lamoon for breach of contract and implied equitable indemnity. 1 Lam-our’s claims alleged that Lamoon breached the settlement agreement between La-moon and Lamour by bringing suit against the Alfalfa Defendants. Lamoon responded with a motion to strike Lamour’s claims under California’s anti-SLAPP law, Cal. Civ.Proc.Code § 425.16. On October 14, 2008, the district court granted plaintiff Lamoon’s anti-SLAPP motion. We affirm.
Lamoon’s claims against the Alfalfa Defendants fall within the categories of protected speech set forth in California’s anti-SLAPP law, Cal.Civ.Proc.Code § 425.16(e). “A claim for relief filed in federal district court indisputably is a ‘statement or writing made before a ... judicial proceeding.’ ” Navellier v. Sletten, 29 Cal.4th 82, 90, 124 Cal.Rptr.2d 530, 52 P.3d 703 (Cal.2002). “The constitutional right of petition encompasses the basic act of filing litigation.” Id. (internal quotation marks omitted). Lamour’s claims were a direct response to Lamoon’s protected act of filing suit against the Alfalfa Defendants. They therefore “arise[ ] from” La-moon’s protected speech or petitioning. See Vess v. Ciba-Geigy Corp. USA, 317 F.3d 1097, 1110 (9th Cir.2003).
Lamour has not met its burden of demonstrating that its claims are “legally sufficient and supported by a prima facie showing of facts to sustain a favorable judgment if the evidence submitted by [Lamour] is credited.” Metabolife Int’l, Inc. v. Wornick, 264 F.3d 832, 840 (9th Cir.2001) (quoting Wilcox v. Superior Court, 27 Cal.App.4th 809, 823, 33 Cal.Rptr.2d 446 (Cal.Ct.App.1994), overruled on other grounds by Equilon Enters., LLC v. Consumer Cause, Inc., 29 Cal.4th 53, 67, 124 Cal.Rptr.2d 507, 52 P.3d 685 (Cal.2002)).
Lamour has not demonstrated a probability of success on the merits of its breach of contract claim. If the Alfalfa Defendants are covered agents or affiliates of Lamour, Lamour is itself in breach of the settlement and Consent Judgment because of the Alfalfa Defendants’ infringing acts. If the Alfalfa Defendants are not covered by the settlement agreement, they are independent infringers of Lamoon’s trademark. In neither case does Lamoon’s lawsuit breach the terms of the settlement agreement with Lamour. Either Lamoon is bringing suit to enforce the agreement, or it is bringing suit against entities not parties to the agreement. The fact that those parties sought indemnity and contri *797 bution from Lamour does not breach La-moon’s promise not to bring suit against Lamour.
Lamour has also failed to demonstrate a probability of success on the merits of its equitable indemnity claim. Lamoon is not seeking to recover twice, but to enforce the terms of the settlement and injunction.
We also affirm the district court’s decision not to grant Lamour leave to amend its complaint. “A district court does not err in denying leave to amend where the amendment would be futile.” Gardner v. Martino, 563 F.3d 981, 990 (9th Cir.2009). Both of Lamour’s claims depend on the faulty premise that Lamoon’s suit breaches the agreement between them. Because Lamour’s claims have underlying legal deficiencies that cannot be cured, amendment would be futile.
AFFIRMED.
This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
373 F. App'x 795, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lamoon-inc-v-lamour-nail-products-inc-ca9-2010.